A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients Fisher, G. A., Lakhani, N. J., Eng, C., Hecht, J., Bendell, J. C., Philip, P., O'Dwyer, P. J., Johnson, B., Kardosh, A., Ippolito, T. M., Wang, Y. V., Agoram, B., Volkmer, J., Maute, R., Chico, I., Chao, M., Takimoto, C. M., Patnaik, A. AMER SOC CLINICAL ONCOLOGY. 2020

View details for Web of Science ID 000530922700108